A series of triterpene dimers bearing different scaffold were designed and synthesized via CuAAC reaction. Their anti-HCV entry activities were evaluated by HCVpp and VSVpp entry assays. It was found that echinocystic acid (EA) and its dimer were still necessary for maintaining anti-HCV entry activity, and replacement of EA by other triterpenes might significantly decrease its anti-viral activities. Using a linker bearing a piperazine group, compound 14 dramatically increased its potency with IC50 at 2.87 nmol/L. In addition, the undesired hemolytic effect of all these compounds was removed.National Natural Science Foundation of China [81560560]; Open-Fund Program of the State Key Laboratory of Natural and Biomimetic Drugs [K20160209]; ...
BACKGROUND & AIMS: Interferon-based therapies for hepatitis C virus (HCV) infection are limited by s...
AbstractChronic hepatitis C virus (HCV) infection has become a major public health burden worldwide....
Hepatitis viral infection is a leading cause of chronic hepatitis, cirrhosis, and hepatocellular car...
The development of entry inhibitors is an emerging approach to the prevention and reduction of HCV i...
Hepatitis C virus (HCV) entry is a key target for the treatment of chronic HCV infection. In our con...
A series of echinocystic acid (EA) 28-COOH derivatives was synthesized, and their anti-HCV entry act...
Development of hepatitis C virus (HCV) entry inhibitors represents an emerging approach that satisfi...
Development of hepatitis C virus (HCV) entry inhibitors represents an emerging approach that satisfi...
To elucidate the pharmacophore of echinocystic acid (EA), an oleanane-type triterpene displaying sub...
Since the influenza viruses can rapidly evolve, it is urgently required to develop novel anti-influe...
Synthesis and anti-hepatitis C virus (anti-HCV) effects of certain 3-amino-2-hydroxy-propoxy isoflav...
Influenza virus is a major human pathogen that causes annual epidemics and occasional pandemics. Rec...
Since the first submission of this article, another report on the antiviral effect of EGCG on HCV en...
[[abstract]]Hepatitis C virus (HCV) infection is a severe liver disease that often leads to liver ci...
The Hepatitis C virus (HCV) is a blood borne virus currently infecting almost 5 million people in th...
BACKGROUND & AIMS: Interferon-based therapies for hepatitis C virus (HCV) infection are limited by s...
AbstractChronic hepatitis C virus (HCV) infection has become a major public health burden worldwide....
Hepatitis viral infection is a leading cause of chronic hepatitis, cirrhosis, and hepatocellular car...
The development of entry inhibitors is an emerging approach to the prevention and reduction of HCV i...
Hepatitis C virus (HCV) entry is a key target for the treatment of chronic HCV infection. In our con...
A series of echinocystic acid (EA) 28-COOH derivatives was synthesized, and their anti-HCV entry act...
Development of hepatitis C virus (HCV) entry inhibitors represents an emerging approach that satisfi...
Development of hepatitis C virus (HCV) entry inhibitors represents an emerging approach that satisfi...
To elucidate the pharmacophore of echinocystic acid (EA), an oleanane-type triterpene displaying sub...
Since the influenza viruses can rapidly evolve, it is urgently required to develop novel anti-influe...
Synthesis and anti-hepatitis C virus (anti-HCV) effects of certain 3-amino-2-hydroxy-propoxy isoflav...
Influenza virus is a major human pathogen that causes annual epidemics and occasional pandemics. Rec...
Since the first submission of this article, another report on the antiviral effect of EGCG on HCV en...
[[abstract]]Hepatitis C virus (HCV) infection is a severe liver disease that often leads to liver ci...
The Hepatitis C virus (HCV) is a blood borne virus currently infecting almost 5 million people in th...
BACKGROUND & AIMS: Interferon-based therapies for hepatitis C virus (HCV) infection are limited by s...
AbstractChronic hepatitis C virus (HCV) infection has become a major public health burden worldwide....
Hepatitis viral infection is a leading cause of chronic hepatitis, cirrhosis, and hepatocellular car...